About Us
About
Peter Josling is Director of the Sussex based Herbal Research Centre. He is a trained biochemist graduating from Nottingham University in England and he gained a PhD in natural medicine in 2005 from Redding University. He has had over 25 years experience in the International Health Food arena devoting his time to conducting and publishing clinical studies and writing scientific articles on a wide variety of natural products including garlic, ginger, ginkgo biloba, phosphatidyl serine, hypericum, saw palmetto, cellulose (first published), vitamin C, black elderberry, magnesium (first published) and allicin (first published).
Simultaneously he set up Allicin International Limited in 2000 and brought to market the first stabilised allicin extract from fresh garlic stocked in Boots and many independent Healthfood Retailers. This brand Allimax/Allicinmax was quickly adopted in 5 international markets in the first year after launch utilising Peters contacts. The business grew to a turnover in excess of £2 million per annum until Peter sold his minority shareholding in 2020. Many research projects were completed under Peters supervision including the now gold standard double blind evaluation on preventing and treating the common cold.
Peter has recently set up Dr Garlic Limited and launched his own stabilised garlic and allicin extract known as Allicin EXTRA. This extract is free from maltodextrin and other fillers as it is air dried and shows superior biological activity to existing stabilised extracts.
Previously Peter spent a number of years in the pharmaceutical industry and also in medical publishing. He published the first data on the use of garlic extracts for reducing cholesterol and blood pressure.
Dr Peter D Josling
Director and Chief Clinical Scientist of the Herbal Research Centre based in Battle England.
Qualifications
PhD Natural Medicine specialising Herbal Medicine
Current Research and Related Activities
- Isolation and purification of novel aqueous based phytochemicals. Including the use of MALDI – TOF and supercritical fluid extraction methods.
- Antimicrobial activity of novel aqueous based phytochemicals especially allicin
- Multi-Drug resistant bacteria and infectious diseases, in particular MRSA and TB.
- Effect of phytochemicals on quorum sensing in MRSA.
- Anti-viral activity of several naturally occurring plant extracts including allicin - ongoing
- The formulation for preventing colds utilising garlic and HPMC dosed intra nasally available in 15 countries - ongoing
News and Media
- Appearances on Sky, BBC, Channel 4 and Channel 5 TV on MRSA
- Consultant to National news papers on Garlic
- Consultant to UK Science Media Centre on Garlic
- Numerous radio interviews in the UK, Europe, Japan and the USA and Canada.
Publications
Selected Research Publications
- Cutler RR, Josling PD and Bennett NJ (2005) Treatment of chronic MRSA infections using a novel aqueous extract of Allicin (AB1000). Clinical Microbiology and Infection. 11: suppl2. p515
- Josling PD Pesewu GP, Cutler RR and Humber DP (2006) Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA. submitted to Journal of Ethnopharmacology June 2006
- Cutler, R.R., Cutler, S.J., Josling, P.D., Wilson, P. (2001) Activity of a Novel, Stable, Allicin extract , in liquid and cream formulations, against Methicillin resistant Staphylococcus aureus (MRSA) including Mupirocin resistant MRSAs, Interscience Congress on Antimicrobial Agents and Chemotherapy, Chicago 2001, Abstract 2279. ASM publications
- Cutler RR, Josling PD, (2003) The activity of allicin against GISA. Institute for Biomedical Sciences congress, Birmingham Sept 2003
- Josling P D (2001) Preventing the common cold with a garlic supplement: A double blind placebo controlled study; Advances in Therapy Jul-Aug: 18 (4)
- Cutler, RR, Josling PD (2002) A Stabilized, Natural, Allicin a Novel Phyto-chemical with the Potential to Combat Diseases Caused by Multiply Antibiotic Resistant Staphylococcus aureus (MRSA). Nursing Practice, March 2002.
- Cutler RR. Josling PD (2006) Activity of Allicin, Alchornea and Cryptolepis extracts against MRSA . presentation from APS natural products meeting published in the Journal of Pharmacy and Pharmacology 2006
- Josling P D, Steadman S, (2003) Use of Cellulose powder for the treatment of seasonal allergic rhinitis Advances in Therapy Jul-Aug: 20(4); 213-219
- Methyl-cellulose powder for prevention and management of nasal symptoms Todor A. Popov ,Nils Åberg,Jean Emberlin,Peter Josling,Natalia I Ilyina,Nikolai P Nikitin &Martin Church 885-892 | Received 23 Jul 2017, Accepted 31 Aug 2017
Conference Papers
- Cutler, R.R., Cutler, S.J., Josling, P.D., Wilson, P. (2001) Activity of a Novel, Stable, Allicin extract, in liquid and cream formulations, against Methicillin resistant Staphylococcus aureus (MRSA) including Mupirocin resistant MRSAs, Interscience Congress on Antimicrobial Agents and Chemotherapy, Chicago 2001, Abstract 2279. ASM publications
- Cutler RR, Josling PD (2003) The activity of allicin against GISA. Institute for Biomedical Sciences congress, Birmingham Sept 2003
- The use of garlic extracts for boosting the immune system and controlling blood pressure and cholesterol – antibiotic conference Budapest Hungary 2013
- The use of stabilised allicin in the treatment of Lyme Disease - Eger Hungary 2015